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ABSTRACT 
Objective: Erythrina variegata had been widely used for its reported biological activity in indigenous system of medicine. The present investigation 
was carried out to find the anti-inflammatory effect of ethanolic extract of Erythrina variegata in albino rats.  
Methods: The anti-inflammatory activity was evaluated using acute inflammatory model like carrageenan induced paw edema and chronic 
inflammatory model like cotton pellet induced granuloma respectively.  
Results: The ethanolic extract in different doses (200, and 400mg/kg, p. o) exhibited dose dependent and significant antiinflammatory activity in 
acute and chronic model of inflammation. 
Conclusion: The alcoholic extract of Erythrina variegata has anti-inflammatory activity. This activity was related to the dose and these results 
corroborate the potential traditional use of the plant in folk medicine. 
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INTRODUCTION 
Pain and inflammation is a common complaint in most patients 
suffering from disease conditions. Inflammation is a host defense 
mechanism to combat or overcome the invading pathogen or the 
foreign particles [1]. Non-steroidal anti-inflammatory drugs 
(NSAIDs) make up one of the largest 
The genus
groups of drugs used for pain 
and inflammation. Currently available anti-inflammatory agents are 
associated with unwanted side effects and have their own 
limitations [2]. Inflammation is the response of living tissues to 
injury. It involves a complex array of enzyme activation, mediator 
release, and extravasations of fluid, cell migration, tissue breakdown 
and repair [3]. Inflammation is one among them, conventional drugs 
used to ameliorate this phenomenon are either too expensive or 
toxic and not commonly available to rural folks that constitute the 
major populace of the world, this study therefore seek to assess 
Erythrina variegata for anti-inflammatory activity and analgesic 
effects in experimental animal models. 
 Erythrina comprises of about 110 species of trees and 
shrubs. The name “coral tree” is used as a collective term for these 
plants. Coral tree is indigenous to the Old World tropics, possibly 
originally from India to Malaysia, but is native of ancient westward 
to Zanzibar and eastward to eastern Polynesia (the Marquesas). It is 
typically found on sandy soil in the littoral forest, and sometimes in 
coastal forest up to 250 m (800 ft) in elevation. The coral tree is 
cultivated particularly as an ornamental tree and as a shade and soil 
improvement tree (it fixes nitrogen) for other tree crops such as 
coffee and cacao. The most attractive type, var. variegata, is grown for 
its variegated leaves, as well as its seasonal showy red flowers [4-6]. 
This fast-growing, 50-60 feet tall and wide deciduous tree with 
green and yellow-variegated, 6-inch-long leaves creates a broad 
canopy but has spiny branches. In spring, before the leaves appear, 
coral tree is decorated with showy red blossoms, each flower 2.5 
inches long and arranged in dense, six-inch-long racemes. These 
blooms are followed by 12-inch-long, red/brown seedpods which 
contain poisonous seeds [7]. Studies on phyto chemical of Erythrina 
variegata species have demonstrated alkaloids and flavonoids as 
major constituents. Different parts of E. Variegata 
Phytochemical investigations on the plant revealed the presence of 
alkaloids [13], flavanoids and isoflavanoids [14-18]. Phenyl coumarins 
[19], lectins [20], flavones glycosides [21], steroids and fatty acids [22]. 
The present study involves estimation anti-inflammatory activity of 
ethanolic extract of E. variegata by Carrageenan induced rat paw 
oedema model and Cotton Pellet Induced Granuloma Animal Model. 
have used in 
traditional medicine as nervine sedative, febrifuge, anti-asthmatic 
and antiepileptic [8]. In the some experiments, it has potential 
effects for treatment of some diseases like convulsion, fever, 
inflammation, bacterial infection, insomnia, helminthiasis, cough, 
cuts and wounds [9-12]. A survey of literature indicated no systemic 
approach has been made to evaluate the anti-inflammatory potential 
of E. variegata by in vivo method.  
MATERIALS AND METHODS 
Plant material 
The plant Erythrina Variegata, collected from the surrounding fields 
of Narsapur forest and was identified by Botanist. The leaves 
collected in the month of January were dried in the shade at room 
temperature and size reduced to coarse powder. 
Preparation of extract 
The coarse powder was extracted with ethanol (95%) and the 
residue was evaporated under reduced pressure in the rotary 
vacuum evaporator at 60°C to obtain a dark brown colored molten 
mass. The percentage yield was found to be 12.7% w/w. 
Anti-inflammatory activity 
Carrageenan induced rat paw oedema model: [23, 24] 
Albino rats of either sex weighing 150 – 200 g were selected. They 
were maintained on the standard pellet diet and free access to 
water. The animals were divided into 6 groups of each containing six 
animals. The various groups treated were as follows:  
Group A - Normal Control (treated with 0.2 ml of 2 % Tween -80 p. o.) 
Group B - Diclofenac sodium (20 mg / kg, p. o.) 
Group C - Alcoholic extract (200 mg / kg, p. o.) 
Group D - Alcoholic extract (400 mg / kg, p. o.) 
The normal control, Diclofenac sodium and test extracts were 
administered to the rats 30 minutes before the injection of 0.1 ml of 
1% carrageenan suspension in normal saline at sub plantar region of 
the left hind paw, and the right hind paw served as reference. 
Immediately thereafter the oedema volume of the injected paws was 
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measured plethysmographically by mercury displacement 
method. For comparison purpose, the volume of oedema at 
various prefixed time intervals (0,1,2,3,4 hours) was measured. 
The difference between paw volumes of the treated animals was 
measured and the mean oedema volume was calculated. 
Percentage reduction in oedema volume was calculated by using the 
formula: 
% reduction = 
Vo − Vt
Vt
 × 100 
Where, 
Vo = Volume of the paw of control at time‘t’ 
Vt = Volume of the paw of drug treated at time‘t’. 
From the data, the mean oedema volume, standard deviation (S. D.), 
standard error (SEM) and percentage reduction in oedema were 
calculated. 
The results of all the experiments conducted were subjected to one 
way analysis of variance (ANOVA) and Dunnet’s test. 
Cotton pellet induced granuloma animal model [25-26] 
Animals were divided into four groups of six animals in each group 
as follows:  
Group I: control received distilled water.  
Group II: Animal treated with Dexamethasone (Dose: 0.5 mg / kg) 
Group III: Animals treated with extract (Dose: 200 mg / kg)  
Group IV: Animal treated with extract (Dose: 400 mg / kg) 
At the end of the experimental period, rats were fasted overnight 
and the anesthetized rats were sacrificed by cervical decapitation. 
The blood sample was collected for Total W. B. C count and spleen 
weight. 
Inflammation was induced by cotton pellet granuloma model 
(Sub acute). This method was adopted by D’Arcy (1960) which 
was carried out by using sterilized cotton pellet implantation 
method in rats. Under light ether anesthesia, by using blunted 
forceps and subcutaneous tunnel was made and sterilized cotton 
pellets (10±1 mg) were implanted in the axilla and groin region of the 
rat. After recovering from Anaesthesia, animals were treated orally 
with vehicle control (Distilled water 10 ml / kg), Dexamethasone and 
various doses of the herbal extract for consecutive 7 days, once per 
day. They were sacrificed on day 8th by cervical dislocation and the 
pellets were removed, freed from extraneous tissue and dried at 600C 
for 24 hrs. The percentage inhibition of the dry weight of the 
granuloma were calculated and compared. 
Results were expressed as mean±Standard deviation (SD). Statistical 
analysis was performed using One-way analysis of variance 
(ANOVA). P
RESULTS 
<0.05 was considered statistically significant. 
Carrageenan induced rat paw oedema model 
The two extracts of leaves of Erythrina Variegata at dose of 200 and 
400 mg / kg exhibited significant anti-inflammatory activity in acute 
paw oedema model. 200 mg/kg dose of Alcoholic extract exhibited 
maximum inhibition of 56.23% and 400mg/kg dose of alcoholic 
extract showed maximum inhibition of 71.66%, the Diclofenac 
sodium has shown reduction in oedema volume by 75.73% in 
carrageenan induced rat hind paw oedema model. 
 
Table 1: Anti-inflammatory activity of crude extract of Erythrina variegata by carageenan induced rat paw oedema 
Group % Increase in paw volumes (ml ×1000) ± SEM (percent inhibition) % reduction 
(after 4 hr) 1 hr 2 hr 3hr 4hr 
Control 0.36 ±0.01 0.69 ±0.03 0.73 ±0.01 0.72± 0.01  
Diclofenac sodium (20 mg/kg) 0.21±0.01 0.23±0.02 0.21±0.01 0.17±0.02 75.73 
E. variegata (200 mg/kg) 0.24±0.01 0.37±0.01 0.22±0.03 0.31±0.04 56.23 
E. variegata (400 mg/kg) 0.32±0.04 0.23±0.03 0.18±0.01 0.20±0.01 71.66 
 
Cotton pellet induced granuloma formation 
The alcoholic extract at different doses and standard drug was 
evaluated by cotton pellet induced granuloma formation to 
understand its potential in sub-acute inflammatory phase. Table-2, 
indicates the significant (p<0.05) reduction of wet weight and dry 
weight of the cotton pellet. The standard drug dexamethasone 
produces maximum activity by inhibiting the wet weight and dry 
weight of cotton pellet 51.45% and 44.77% respectively. Two 
different dose (200, 400 mg/kg) showing significant reduction of 
wet weight and dry weight of cotton pellet at 42.67%, 28.15% and 
27.74%, 26.54% respectively. 
 
Table 2: Effect of E. variegata on wet weight and dry weight cotton pellets 
Group Mean wet weight of cotton % of inhibition Mean dry weight of cotton % of inhibition 
control 180.29 ± 12 - 51.71 ± 0.59 - 
Standard 
Dexamethasone 
83.75 ± 5.75 51.45* 23.35 ± 1.63 44.77* 
E. variegata  
(200 mg/kg) 
90.25 ± 0.86 42.67** 33.81 ± 0.90 28.15** 
E. variegata 
(400 mg/kg) 
129.99 ± 3.48 27.74* 36.88 ± 0.95 26.54* 
* Denotes significance at the level of p ≤ 0.05  
** Denotes significance at the level of p ≤ 0.01 
 
DISCUSSION 
Carrageenan-induced hind paw oedema is the standard 
experimental model of acute- inflammation. The time course of 
oedema development in carrageenan-induced paw oedema model in 
rats is generally represented by a biphasic curve [27]. The first 
phase of inflammation occurs within an hour of carrageenan 
injection and is partly attributed to trauma of injection and also to 
histamine, and serotonin components.  
The second phase is associated with the production of bradykinin, 
protease, prostaglandin, and lysosome. Prostaglandins (PGs) play a 
major role in the development of the second phase of inflammatory 
reaction which is measured at +3 h [28]. 
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The doses 200 mg/kg and 400 mg/kg of alcoholic extract of 
Erythrina variegata produced a significant inhibition of carrageenan 
induced paw oedema at +3h and +6h. Therefore, it can be inferred 
that the inhibitory effect of alcoholic extracts of Erythrina variegata 
on carrageenan induced inflammation could be due to inhibition of 
the enzyme cyclooxygenase and subsequent inhibition of 
prostaglandin synthesis. Significant inhibition of paw oedema in the 
early hours of study by Erythrina variegata could be attributed to 
the inhibition of histamine and/or serotonin. The decrease in paw 
oedema inhibition at +6h may be attributed to the termination of 
test drug action.  
Cotton pellet granuloma is one of the exudative of inflammation and the 
cotton pellet granuloma is taken as proliferate phase of inflammation. 
During the inflammatory process migration of WBC takes place which is 
the biological marker. Enlargement of the spleen occur as spleen has the 
phagocyte nature. It was observed that the extract of the E. Variegata 
significantly reduced the granuloma formation in rat. It was found that 
the extract at the dose 200 mg/kg and 400mg/kg produced a significant 
anti-inflammatory activity by reducing the dry weight and wet weight of 
granuloma, inhibiting the migration of WBC. The spleen weight also 
significantly decreases by the extract. The antiinflammatory potential 
may be attributed to the presence of phytoconstituents such as 
polyphenolic compound (flavonoids) and steroidal saponin. The better 
suggestion is that the lower dose (200mg/kg body weight) produces a 
better activity than the higher dose. 
CONCLUSION 
On the basis of these findings, it may be inferred that alcoholic 
extract of Erythrina variegata has anti-inflammatory activity. This 
activity was related to the dose and these results corroborate the 
potential traditional use of the plant in folk medicine. At present, 
there are no reports on an investigation to identify the active 
components present in ethanolic extract of Erythrina variegata. 
Further investigations are anticipated to identify the active 
components and lead to their further clinical use. 
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